Evidence map›Paper›PMID 42036955›Full record

ReviewBiochemistry2026

Structural Principles of Covalent Flavin Modification in Oxidoreductases.

John J Tanner

Abstract readReview
In one paragraph

Review in Biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

John J TannerDepartments of Biochemistry and Chemistry, University of Missouri, Columbia, Missouri 65211, United States.ORCID 0000-0001-8314-113X

Funding

Investigating the Proline Cycle as a Potential Cancer Therapy TargetR01GM132640 · NIGMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI Donald F Becker, JOHN J TANNER · 2020 to 2026
$1.9M
NIGMS NIH HHS R01 GM132640
6 · The paper itself

Abstract

Flavin-dependent oxidoreductases participate in a remarkably diverse array of biochemical transformations, enabled by the redox and covalent versatility of the isoalloxazine cofactor. The N5 and C4a atoms of the flavin are central to catalysis and, in selected cases, serve as loci of irreversible covalent modification. This review focuses on structurally validated examples of covalent inactivation of flavoenzymes in which the chemical nature of the flavin adduct has been established by X-ray crystallography, beginning with the historically important reversible N5 sulfite adduct and extending to mechanism-based irreversible inactivation. Mining of the Protein Data Bank reveals that covalent flavin modification occurs across multiple enzyme families, including monoamine oxidases, lysine-specific demethylase 1, proline dehydrogenase, spermine/polyamine oxidases, and cytokinin oxidase/dehydrogenase. These systems illustrate a limited but recurring set of structural outcomes, most commonly N5 alkylation or C4a alkylation, frequently accompanied by flavin reduction and characteristic butterfly bending of the isoalloxazine ring. A theme emerging from the structural record is the susceptibility of amine oxidases and dehydrogenases among covalently inactivated flavoenzymes. This prevalence reflects intrinsic mechanistic features of C-N bond oxidation─particularly iminium formation proximal to reduced flavin─that predispose these enzymes to irreversible flavin modification. In contrast, other flavoenzyme classes rarely generate electrophiles positioned for flavin attack, rendering stable covalent modification less common. By integrating structural, mechanistic, and inhibitor-design perspectives, this review highlights both the chemical disposition underlying covalent flavin inactivation and the constraints that shape its distribution across flavoprotein biochemistry.

Indexed as

FlavinsOxidoreductasesCrystallography, X-RayFlavoproteinsHumansModels, MolecularOxidation-ReductionOxidoreductases Acting on CH-NH Group DonorsFlavinsFlavoproteinsisoalloxazineOxidoreductasesOxidoreductases Acting on CH-NH Group Donorscovalent inhibitioncovalent modificationflavoenzymesX-ray crystallography

Identifiers

PMID42036955
PMCPMC13155685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.